Cholesterol Study

Do you think you might have elevated cholesterol? We invite you to come in for a free cholesterol check to see if you are eligible to participate in our study.

We are conducting a study to assess the effectiveness of a specialised supplement on cardio-metabolic parameters and inflammatory markers in men and women with elevated cholesterol.

Background

Hypercholesterolemia is elevated cholesterol in the blood and is a well-known risk factor for cardiovascular diseases. Omega-3 essential fats cannot be made by the body and must be consumed in the diet or via supplementation. Omega-3 essential fatty acids are known to have a beneficial effect on cholesterol levels and may offer protection against cardiovascular diseases.

About the Product
  • The study product is a type of omega-3 essential fatty acid.
Study Outline

Potential participants will be invited to attend the study site for final screening and enrolment. The screening process includes a finger prick test to determine cholesterol levels.

Enrolled participants will complete questionnaires, have a body composition assessment, blood test and will be allocated into either the treatment of placebo group.

You will be asked to take the allocated product daily for 6 months and attend the study site every 2 months for an assessment (at the end of months 2, 4 & 6).

Each assessment will involve questionnaires, a progress interview, body composition assessment, finger prick test and blood test.

Benefits to participation
  • Blood analysis and cholesterol check at the commencement and throughout the study.
  • You will be helping to advance medical research.
Who can participate?
  • Males & Females over 25 years with elevated cholesterol
  • Normal dietary habits (no specialised diet such as vegan or macrobiotic)
  • Otherwise healthy
  • Healthy weight range with BMI between 18.5-29.9
  • Ability to consent to participation in the study
Ethics Approval

This study has been approved by the Bellberry Human Research Ethics Committee. Approval number:  2011-12-916

This study is registered on the Australian and New Zealand Clinical Trial Registry under Registration Number:  ACTRN12617000872336

Your Rights
  • Your records relating to this study and any other information received will be kept strictly confidential.
  • Upon completion, the results of the study will be shared with you.
Location

Newstead, Brisbane